Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors)
against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and …

Acquired haemophilia is a potentially life‐threatening bleeding disorder caused by the
development of autoantibodies against coagulation factors, most commonly against factor …

Acquired hemophilia A (AHA), a rare bleeding disorder caused by neutralizing
autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without …

Acquired hemophilia A (AHA) is a severe bleeding disorder caused by inhibiting
autoantibodies to coagulation factor VIII (FVIII). For hemostatic treatment, bypassing agents …

Acquired hemophilia A is a rare bleeding disorder caused by autoantibodies to coagulation
FVIII. Bleeding episodes at presentation are spontaneous and severe in most cases. Optimal …

Acquired hemophilia A (AHA) is an autoimmune disease caused by an autoantibody to
factor VIII. Patients are at risk of severe and fatal hemorrhage until the inhibitor is eradicated …

Acquired hemophilia A (AHA) is caused by autoantibodies against factor VIII (FVIII).
Immunosuppressive treatment (IST) results in remission of disease in 60% to 80% of …

To the Editor: Acquired hemophilia A (AHA) is a rare bleeding disorder caused by circulating
autoantibodies directed against clotting factor VIII (FVIII). 1, 2 It involves more frequently …

We read with interest the case report by Radwi and Farsi of a 69-year-old man with acquired
hemophilia A (AHA) following vaccination with the Pfizer-BioNTech SARS CoV-2 mRNA …

ABSTRACT Objectives: Acquired hemophilia A (AHA) is a rare, but potentially life-
threatening, bleeding disorder caused by an autoantibody against factor VIII that interferes …